The Healthcare Sector
India is the 'pharmacy of the world', providing a massive percentage of global generic drugs and vaccines. Investing in major players like Sun Pharma, Cipla, and Dr. Reddy's—or multi-specialty hospital chains like Apollo—provides a great defensive hedge because people require medicine and treatment regardless of economic slowdowns.
Navigating FDA Risks
- US FDA Approvals: When Indian pharma companies invent or copy a complex generic drug, gaining US FDA approval can skyrocket stock value immediately.
- Warning Letters: Conversely, if the FDA finds hygiene issues at an Indian plant during inspection, they issue a Warning Letter, causing the stock to crash instantly due to sudden export blocks.